Europe e-pharmacy market was valued at USD 29.65 billion in 2023 and is expected to reach USD 79.43 billion by 2029, growing at a CAGR of 17.85%.

The demographic trend of an ageing European population is reshaping the retail market for medical supplies, notably due to the increased prevalence of issues like reduced mobility and hearing impairment among seniors. This shift bolsters the sales of medical and orthopaedic supplies across the continent, particularly as seniors become a more significant consumer segment for these products. Traditional pharmacy chains are diversifying into the medical devices sector, offering items like blood pressure monitors at competitive prices and challenging specialised retailers. Online retailers compound the competition with lower-priced offerings attributable to their minimal operational expenses. Major companies are strategically acquiring smaller businesses to enhance their global reach and strengthen their European market standing. These trends underline a robust market environment catering to the senior demographic's needs, with expanding product ranges, competitive pricing and industry consolidation contributing to overall profitability and dynamism within the sector. However, online retailers are capturing a larger market share by offering basic medical supplies at competitive prices and providing a more convenient shopping experience. This shift is leading to a decline in revenue within the traditional medical supply industry. Industry revenue is forecast to decline at a compound annual rate of 5.4% over the five years through 2024 to €373.7 billion, including estimated drop of 3.5% in 2024, while the average industry profit margin is expected to reach 9.5%. A hike in the hearing aid market is likely because of rising healthcare standards. In response, industry trends suggest medical orthopaedic retailers will diversify their offerings and add services like hearing tests to enhance market presence. Retailers are capitalising on the opportunity to facilitate increased hearing aid sales through the provision of comprehensive services, meeting the evolving demands of an ageing population in pursuit of hearing health solutions. Industry revenue is forecast to grow at a compound annual rate of 1.1% over the five years through 2029 to €395.3 billion.

For member countries of the European Union, it was predicted that there will be a 6.3 percent growth of the pharmaceutical market within the given period. This statistic depicts the market growth forecast for European pharmaceutical markets compared to global developments between 2022 and 2027.

The European Pharmaceutical Market Report Covers Pharma Logistics Companies and is Segmented by Product (Generic Drugs and Branded Drugs), Operation (Cold Chain Transport and Non-Cold Chain Transport), Application (Biopharma and Chemical Pharma), Transport (Airways, Railways, Roadways, and Seaways), and Geography (Germany, The United Kingdom, The Netherlands, France, Italy, Spain, Poland, Belgium, Sweden, and the Rest of Europe). The Report Offers the Market Sizes in Value Terms (USD) for all the Above Segments.

Snapshot img

EPharmacy Market Size 2025-2029

The EPharmacy market size is forecast to increase by USD 148.5 billion at a CAGR of 21.2% between 2024 and 2029.

The market is witnessing significant growth due to several key trends. The availability of advanced robotic pharmacy prescription dispensing systems and pharmacy automation systems is driving market growth. Artificial intelligence and medical devices are being integrated into these systems to enhance accuracy and efficiency. Additionally, the increasing popularity of e-commerce and the convenience it offers to consumers are fueling market expansion. The integration of digital health technologies is further improving the delivery of healthcare services, making it easier for consumers to manage their health remotely. However, challenges such as the growing acceptance of EPharmacy services in newly regulated European states and the risk of illegal and counterfeit trading of drugs through EPharmacy platforms remain major concerns. The rise of health and wellness trends is also contributing to the demand for more accessible, convenient, and personalized healthcare solutions. Overall, the market is expected to continue its growth trajectory, driven by technological advancements, changing consumer preferences, and an increasing focus on health and wellness.

What will be the Size of the EPharmacy Market During the Forecast Period?

Request Free Sample

The market, encompassing mail-order medicines and over-the-counter products sold through e-commerce channels, continues to experience significant growth as more patients turn to the convenience of online purchasing for their healthcare needs. With an increasing number of chronically ill patients and elderly citizens seeking easier access to prescription medicines and healthcare products, market sales have been on an upward trajectory. Tech-savvy consumers, including millennials, are driving the demand for digitalization in healthcare services, leading to the emergence of startups leveraging information technologies, algorithms, and artificial intelligence to enhance customer satisfaction. The integration of telemedicine adoption, virtual healthcare services, remote patient monitoring, and patient engagement platforms further underscores the digital health trends shaping the market.
Regulations governing online pharmacies and healthcare data security remain critical concerns for market participants. The pharmaceuticals industry continues to innovate, with advancements in healthcare technology and the increasing popularity of virtual healthcare services. Online pharmacy marketing and digital health investment are key areas of focus for market players.

How is this EPharmacy Industry segmented and which is the largest segment?

The EPharmacy industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Product Type

  Medications
  Health and wellness and nutrition
  Personal care and essentials


Drug Class

  Prescription drugs
  Over-the-counter drugs


Distribution Channel

  Mobile applications
  Online platforms


End-user

  Individuals
  Commercial


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK
    France
    Italy


  APAC

    China
    India
    Japan
    South Korea


  South America



  Middle East and Africa

By Product Type Insights

The medications segment is estimated to witness significant growth during the forecast period.

In the modern healthcare landscape, EPharmacy, which encompasses mail-order medicines, e-commerce, and online pharmacies, plays a significant role in delivering prescription medicines and over-the-counter products to patients. This sector caters to the needs of various demographics, including chronically ill patients, elderly citizens, and millennials, through the digitalization of healthcare services. The convenience offered by online platforms, such as doctor consultations, smartphone orders, and doorstep delivery, appeals to tech-savvy consumers. However, regulations are stringent to combat illegitimate online pharmacies and ensure the safety of counterfeit, adulterated, or incorrectly labeled medications. EPharmacy solutions have become vital services, especially during lockdowns and urban center living, where operational costs and infrastructure priorities align with healthcare goals.

The sector includes independent internet-only outlets, electronic subsidiaries of retail pharmacy stores, and delivery companies. Platforms offering online shopping, diagnostics, and prescribed medications have become essential for consumer shopping habits, particularly for those requiring chronic care or living in developing economies. The industry continues to evolve with advancements in

The size and share of the market is categorized based on Application (Consumers Aged 18 And Younger, Consumers Aged 19 To 44, Consumers Aged 45 To 64, Consumers Aged 65 And Older) and Product (Pharmaceutical Ingredient Alteration (pia), Pharmaceutical Application Alteration (paa), Currently Unavailable Pharmaceutical Manufacturing (cupm), Pharmaceutical Dosage Alteration (pda), Specialized Animal Pharmaceutical Manufacturing (sapm)) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).

This statistic displays a forecast from June 2016 for the total pharmaceutical market sales in Europe from 2012 to 2022. The forecast predicts that in 2022 the total from pharmaceutical market sales will amount to approximately 206 billion euros.

Europe Pharmaceutical Warehousing Market Report is Segmented by Type (cold Chain Warehouse, Non-Cold Chain Warehouse), Application (pharmaceutical Factory, Pharmacy, Hospital, and Others), and Geography (Germany, UK, France, Russia, Spain, and the Rest of Europe). The Report Offers Market Size and Forecasts for the Europe Pharmaceutical Warehousing Market in Value (USD) for all the Above Segments.

Snapshot img

Compounding Pharmacy Market Size 2025-2029

The compounding pharmacy market size is forecast to increase by USD 1.74 billion at a CAGR of 2.2% between 2024 and 2029.

The market is experiencing significant growth, driven primarily by the increasing demand for personalized medications, particularly in the area of Hormone Replacement Therapy (HRT). This trend is fueled by the rising preference for customized treatment options that cater to individual patient needs, which cannot be met through mass-produced pharmaceuticals. Additionally, the market is witnessing an upward trajectory due to the expanding patient base, particularly in the geriatric population, who often require customized medications.
However, the market's growth is not without challenges. The unsafe usage of compounded drugs or topical drugs, due to the lack of standardization and regulation, poses a significant risk to patient safety. This issue is of particular concern in the US, where the Food and Drug Administration (FDA) has identified numerous cases of contaminated compounded drugs leading to adverse health effects.
Companies seeking to capitalize on market opportunities must prioritize adherence to regulatory standards and invest in advanced technology to ensure product safety and quality. Navigating these challenges effectively will require a strategic focus on patient safety, regulatory compliance, and operational efficiency.

What will be the Compounding Pharmacy Market Size During the Forecast Period?

Request Free Sample

The market encompasses community-based pharmacies specializing In the custom preparation of sterile and non-sterile medications. These personalized formulations cater to patients with unique requirements, such as allergies to inactive ingredients or specific medication strengths. The market distinguishes between 503A and 503B compounding pharmacies, with the former focusing on small-scale, patient-specific prescriptions, while the latter produces larger batches of sterile medications adhering to more stringent regulations.
Similarly, state pharmacy boards and regulatory bodies, including the Drug Enforcement Administration (DEA), oversee compounding pharmacies to ensure adherence to guidelines. Compounded medications, including sterile and non-sterile forms like liquid, gummy, candy, chewable tablets, and topical ointments, address various medical conditions, such as pelvic pain, acid reflux (using omeprazole or lansoprazole), and anxiety (using diazepam). Backorders for premade medications can be mitigated through compounding, providing patients with timely access to essential medications.

How is this Compounding Pharmacy Industry segmented and which is the largest segment?

The compounding pharmacy industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Product

  Topical medications
  Oral medications
  Parenteral medications
  Others


Therapeutic Area

  Pain management
  Hormone replacement
  Dermal disorders
  Others


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK
    France


  Asia

    China
    India
    Japan
    South Korea


  Rest of World (ROW)

By Product Insights

The topical medications segment is estimated to witness significant growth during the forecast period. Topical medications, encompassing creams, ointments, gels, and other semi-solid dosage forms, are integral to treating various skin conditions. Their unique property of adhering to the application site allows for controlled and sustained release, ensuring therapeutic efficacy. The primary objective for topical drug administration is achieving adequate absorption into the skin's viable epidermis or upper dermis. Sterile and non-sterile compounding pharmacies play a crucial role in preparing customized topical medications, catering to the specific needs of healthcare professionals, patients, families, and pets. These pharmacies, regulated by state boards, follow stringent guidelines to ensure the quality and safety of compounded medications.

Similarly, medications for allergies, inactive ingredients, and premade medications are also compounded when commercially available options are unsuitable. Compounded topical medications are used in various therapeutic areas, such as men's health, dermatology, and veterinary medicine. Healthcare providers, including hospitals and doctor's offices, rely on compounded medications to address individual patient requirements, addressing backorders or customizing medication strengths. FDA-registered outsourcing facilities and drug companies collaborate to produce bulk ingredients and commercial drug products, ensuring a consistent supply of topical medications.

Get a glance at the share of various segments

The size and share of the market is categorized based on Application (App Only, Online Store) and Product (Prescription Drugs, Non-prescription Drugs) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).

The U.S. And Europe Pharmaceutical Manufacturing Market size was valued at USD 412.50 billion in 2023 and is projected to reach USD 654.20 billion by 2032, exhibiting a CAGR of 6.81 % during the forecasts period. The scope of the U. S. and Europe pharmaceutical manufacturing market includes the manufacturing and creating of the medications as well as the pharmaceutical products. This market comprises activities such as formulation of drugs, manufacturing of the drug, testing and certification of the quality, and placing the drug in the appropriate packaging. Some of the uses include formulating prescription medicines, over the counter drugs, and biopharmaceuticals. Such impacts include; growing enrolment of patients on new techniques, rising incidences of persistent diseases and development of technologies in the production of the equipment. Trends include the transformation from a disease-centered approach to a patient-centered one, the continued rise in the polygenic biological medicines and biological generics, integration of innovative practices of manufacturing like continuous processing and automation, and the need to observe regulatory requirements to satisfy the strict standards of the two regions.

Europe Pharmacy POS Software Market Size By Type (Cloud-Based and Web-Based), By Application (Hospitals and Health Systems), By Geographic Scope And Forecast

The Europe Pharmaceutical Contract Manufacturing Market Report is Segmented by Service Type (Active Pharmaceutical Ingredient (API) Manufacturing, Finished Dosage Formulation (FDF) Development and Manufacturing, and Secondary Packaging) and Country (United Kingdom, Germany, France, Italy, and Rest of Europe). The Market Sizes and Forecasts are Provided in Terms of Value (USD) for all the Above Segments.

Europe Pharmaceutical Packaging Market size was valued at USD 6.22 Billion in 2024 and is projected to reach USD 48.03 Billion by 2032, growing at a CAGR of 32.12% from 2026 to 2032.

Key Market Drivers

Aging Population and Increased Medication Consumption: According to Eurostat, the EU’s population aged 65 and older is predicted to grow to 130.2 million by 2050, accounting for 30.3% of the total population, up from 90.5 million (20.3%) in 2019. The European Medicines Agency (EMA) reports that this demographic shift has led to a 42% increase in prescription medication usage between 2018-2023, with the average elderly person in Europe consuming 3.6 prescription medications per day, driving demand for specialized pharmaceutical packaging solutions.

Growth in Biologic Drugs and Cold Chain Packaging: The European Federation of Pharmaceutical Industries and Associations (EFPIA) reports that biologics accounted for 34% of all new medicine approvals in Europe by 2023, up from 22% in 2018.

The Europe Pharmaceutical Blister Packaging Market Report is Segmented by Material (Plastic, Paper, and Aluminum), Technology (Cold Forming and Thermoforming), and Country (the United Kingdom, Germany, Italy, France, Spain, and the Rest of Europe). The Report Offers Market Sizes and Forecasts in Terms of Value (USD) for all the Above Segments.

The industry is an integral part of the pharmaceutical supply chain and the pharmaceutical sector's research and development process, with some of the largest pharma manufacturing companies across the globe being based in Europe. Over the five years through 2024, industry revenue is expected to fall at a compound annual rate of 1% to reach €613 billion, including a fall of 1.5% in 2024. Overall, an ageing population across Europe is widening the available market for manufacturers, with the rising healthcare expenditure of most EU countries supporting the industry. The COVID-19 outbreak skyrocketed the industry’s importance to the functioning of the European economy, with many manufacturers rushing to develop and patent COVID-19 vaccines and other related tests. Spiking hospital admissions during the height of the pandemic heightened demand for various pharmaceutical products. Although EU pharma manufacturers are investing heavily in new treatment research and development, boosting industry growth, they are also facing intense competition from overseas suppliers, particularly from China and India, when it comes to selling intensive-care medical products. Industry revenue is expected to grow at a compound annual rate of 4.9% over the five years through 2029 to reach €779.9 billion. The EU reform of the pharmaceuticals framework will address systemic shortages and ensure the security of the supply of critical medicinal products, boosting industry performance. The rising adoption of big data and new manufacturing practices will speed up the commercialisation of different medical treatments, supporting industry performance.

Total pharmaceutical sales numbers in North America are projected to amount to around 853 billion U.S. dollars in 2028, making it the regional submarket with the highest global pharma sales. Pharmaceutical spending and product revenue In 2026, the United States is projected to spend between 685 and 715 billion U.S. dollars on medicine, making it the country with the highest pharmaceutical spending by far. China, which is estimated to be in second place, has a maximum projected expenditure estimate of 190 billion U.S. dollars for that year. The top pharmaceutical product for 2026 is expected to be Keytruda. Keytruda by Merck & Co is forecast to generate almost 27 billion U.S. dollars in revenue in 2026. Chemical and biological substances Given that U.S. pharmaceutical R&D expenditures are the highest in the world, it comes to no surprise that the United States produces the largest volume of new chemical or biological entities each year. Between 2019 and 2023, American companies introduced a total of 148 new chemical or biological substances. Within the same period, Europe introduced 81 new entities.

The market size of the E Pharmacy Market is categorized based on Application (Commercial, Home) and Product (On-premise, Cloud-based) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).

This report provides insights into the market size and forecasts the value of the market, expressed in USD million, across these defined segments.

The pharmaceutical eCommerce market value is estimated to be US$ 75,527.4 million in 2024. The market is predicted to grow at a CAGR of 14.4% during the forecast period. The market valuation is estimated to reach US$ 290,824.8 million by 2034.

Report Attribute	Details
Pharmaceutical eCommerce Market Size (2024)	US$ 75,527.4 million
Anticipated Market Value (2034)	US$ 290,824.8 million
Projected Growth Rate (2024 to 2034)	14.4% CAGR

Historical Analysis of the Pharmaceutical eCommerce Market Vs Demand Outlook

Attributes	Details
Pharmaceutical eCommerce Market Value (2019)	US$ 54,772.1 million
Historical Market Revenue (2023)	US$ 73,315.6 million
Historical CAGR (2019 to 2023)	7.6%

Country-wise Insights

Countries	CAGR (2024 to 2034)
United States	7%
Germany	8%
United Kingdom	8.7%
India	20.7%
China	16%

Category-wise Insights

Attributes	Details
Top Product Type	Over-the-counter Product
Market Share in 2024	63.7%

Attributes	Details
Top End User	Consumer or Individuals
Market Share in 2024	29.8%

Pharmaceutical eCommerce Market Report Scope

Attribute	Details
Estimated Market Size (2024)	US$ 75,527.4 million
Projected Market Size (2034)	US$ 290,824.8 million
Anticipated Growth Rate (2024 to 2034)	14.4%
Forecast Period	2024 to 2034
Historical Data Available for	2019 to 2023
Market Analysis	US$ million or billion for Value and Units for Volume
Key Regions Covered	North America, Latin America, Europe, Middle East & Africa (MEA), East Asia, South Asia and Oceania
Key Segments Covered	By Product Type, By End Use Verticals, and By Region
Key Companies Profiled	Netmeds Marketplace Ltd. EasyMedico Medlife Amazon. Inc Apotek The Kroger Co. Walgreen Co. Giant Eagle, Inc. Walmart Express Scripts CVS Health Optum, Inc. L Rowland & Co (Retail) Ltd Zur Rose Group AG McKesson Corporation SHOP-APOTHEKE EUROPE N.V. UK Meds Direct Ltd. Walgreens Boots Alliance, Inc. DocMorris
Report Coverage	Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Customization & Pricing	Available upon Request

[236 Pages] The global ePharmacy market is projected to expand at 14.3% CAGR to reach a market valuation of US$ 351.9 billion by the end of 2033, up from the US$ 81.5 billion recorded for 2022.

Attribute	Details
ePharmacies Market Size (2023)	US$ 92.4 Billion
Forecasted Market Value (2033)	US$ 351.9 Billion
Value CAGR (2023 to 2033)	14.3%
Collective Value Share: Top 5 Countries (2022)	58.4%
Key Market Players	Netmeds Marketplace Ltd, EasyMedico, Medlife, Amazon. Inc, Apotek, The Kroger Co., Walgreen Co., Giant Eagle, Inc., Walmart, Express Scripts, CVS Health, Optum, Inc., L Rowland & Co (Retail) Ltd, Zur Rose Group AG, McKesson Corporation, SHOP-APOTHEKE EUROPE N.V., UK Meds Direct Ltd., Walgreens Boots Alliance, Inc., DocMorris

Sales Analysis of ePharmacies (2017 to 2022) Vs. Market Outlook (2023 to 2033)

Market Statistics	Details
Jan–Jun (H1), 2021 (A)	10.89%
Jul–Dec (H2), 2021 (A)	14.09%
Jan–Jun (H1),2022 Projected (P)	10.37%
Jan–Jun (H1),2022 Outlook (O)	11.19%
Jul–Dec (H2), 2022 Outlook (O)	14.66%
Jul–Dec (H2), 2022 Projected (P)	13.71%
Jan–Jun (H1), 2023 Projected (P)	11.21%
BPS Change : H1,2022 (O) - H1,2022 (P)	82↑
BPS Change : H1,2022 (O) - H1,2021 (A)	30↑
BPS Change: H2, 2022 (O) - H2, 2022 (P)	94↑
BPS Change: H2, 2022 (O) - H2, 2021 (A)	56↑

Country-wise Insights

Country	USA
Market Share (2023)	34.6%
Market Share (2033)	44.0%
BPS Analysis	938

Country	China
Market Share (2023)	6.6%
Market Share (2033)	5.4%
BPS Analysis	-126

Country	Germany
Market Share (2023)	6.3%
Market Share (2033)	7.4%
BPS Analysis	102

Country	Australia
Market Share (2023)	5.9%
Market Share (2033)	5.8%
BPS Analysis	-4

Country	Japan
Market Share (2023)	5.3%
Market Share (2033)	5.1%
BPS Analysis	-15